World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01155739
Date of registration: 23/07/2009
Prospective Registration: No
Primary sponsor: University of Lausanne Hospitals
Public title: Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
Scientific title: Etude Prospective Sur l'Impact de l'Utilisation de la Procalcitonine Dans l'évaluation de la Poursuite ou de l'arrêt du Traitement Antibiotique Empirique Lors de péritonites et d'Infections Intra-abdominales
Date of first enrolment: June 2009
Target sample size: 162
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01155739
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Switzerland
Contacts
Name:     Steve Aellen, MD
Address: 
Telephone:
Email:
Affiliation:  Department of visceral surgery, university hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- More than 18 yo

- Patient requiring surgery for peritonitis or intra-abdominal infection following:
perforation, necrosis, previous operation...

- Mannheim Peritonitis score > 14

- SIRS present

- Probability of survival > 72h

- Informed consent by patient/relatives

Exclusion Criteria:

- No SIRS

- Long date corticoid treatment

- Immunosuppression

- Thyroid medullary carcinoma

- Anaphylactic shock

- Acute hepatic deficiency



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Secondary or Tertiary Peritonitis
Intervention(s)
Primary Outcome(s)
antibiotic treatment length, hospitalisation length without antibiotic, infection recurrence, antibiotic cost [Time Frame: at one month and during hospital stay]
Secondary Outcome(s)
Secondary ID(s)
141/08, Propéritonite
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history